Eli Lilly and Company (TSX:LLY)
Canada flag Canada · Delayed Price · Currency is CAD
37.02
+0.09 (0.24%)
At close: Feb 19, 2026

Eli Lilly and Company Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,251,2861,319,3571,000,186692,306470,466316,903
Market Cap Growth
17.50%31.91%44.47%47.15%48.46%62.48%
Enterprise Value
1,301,0771,363,7841,039,381715,104487,742332,087
Last Close Price
37.0239.0828.5121.74--
PE Ratio
44.2246.6265.64100.0455.6644.86
PS Ratio
14.0014.7615.4315.3612.188.84
PB Ratio
34.3936.2648.7148.2632.2627.35
P/TBV Ratio
64.6568.17297.57---
P/FCF Ratio
101.72107.25184.88661.9060.6541.35
P/OCF Ratio
54.2857.2378.83123.6445.8334.00
EV/Sales Ratio
14.5815.2616.0415.8712.639.27
EV/EBITDA Ratio
29.7931.3838.4145.6935.4226.72
EV/EBIT Ratio
32.0133.4942.3952.4441.6531.72
EV/FCF Ratio
105.76110.86192.12683.7062.8843.33
Debt / Equity Ratio
1.651.652.442.441.521.85
Debt / EBITDA Ratio
1.371.371.832.201.611.72
Debt / FCF Ratio
4.894.899.2533.422.862.80
Net Debt / Equity Ratio
1.371.372.172.091.231.28
Net Debt / EBITDA Ratio
1.151.151.651.921.301.20
Net Debt / FCF Ratio
4.054.058.2628.682.311.94
Asset Turnover
0.680.680.630.600.580.59
Inventory Turnover
1.041.041.261.411.621.77
Quick Ratio
0.780.780.570.520.630.80
Current Ratio
1.581.581.150.941.051.23
Return on Equity (ROE)
101.16%101.16%84.26%48.43%62.67%74.52%
Return on Assets (ROA)
19.41%19.41%14.92%11.37%11.00%10.84%
Return on Invested Capital (ROIC)
39.82%43.74%35.54%27.99%33.88%36.42%
Return on Capital Employed (ROCE)
38.40%38.40%33.90%28.10%26.70%24.50%
Earnings Yield
2.26%2.15%1.52%1.00%1.80%2.23%
FCF Yield
0.98%0.93%0.54%0.15%1.65%2.42%
Dividend Yield
0.61%21.05%26.24%27.46%--
Payout Ratio
26.09%26.09%44.19%77.65%56.62%55.30%
Buyback Yield / Dilution
0.53%0.53%-0.09%0.15%0.78%0.09%
Total Shareholder Return
1.14%21.58%26.15%27.61%0.78%0.09%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.